Search results
Hace 4 días · Justin Stebbing shared a post on LinkedIn: . “Really excited to be part of this/communicating author with benefits to patients with ‘cold tumours’.” Source: Justin Stebbing/LinkedIn Justin Stebbing is a visiting Professor of Cancer Medicine and Oncology at Imperial College, London and a Professor of Biomedical Sciences at Anglia Ruskin University (ARU), Cambridge.
Hace 14 horas · Dr. Oreofe O. Odejide de la Dana-Farber Cancer Institute și Harvard Medical School, care nu a fost implicat în studiu, a declarat că aceste rezultate sunt impresionante și că ar putea schimba tratamentul standard pentru pacienții cu limfom Hodgkin clasic în stadiu avansat. "Aceste rezultate sunt cu adevărat remarcabile.
Hace 3 días · He was preceded in death by his father, John Tolman. Visiting hours will be held on July 11, 2024, from 11:00 a.m. to 1:00 p.m., with service and reception following at Hobbs Funeral Home, 671 U.S. Route 1, Scarborough, Maine 04074. In lieu of flowers, the family requests that donations be made to Dana-Farber Cancer Institute or Hospice of ...
Hace 5 días · Recently, we examined the utility of NGS for detection of MMR-D in a retrospective study of 1,768 patients with CRC or EC at Brigham and Women’s Hospital/Dana-Farber Cancer Institute. 15 In this study, we compared results from the Oncopanel NGS assay to IHC for the 4 MMR genes.
Hace 14 horas · However, only women with severe obesity (BMI of 35 or higher) had higher breast cancer mortality. Ultimately, while metabolic syndrome and obesity both influence breast cancer risk and mortality, they do so in different ways, the study authors concluded. “Postmenopausal women with higher MetS scores are a previously unrecognized population at ...
Hace 5 días · 30 The Institute of Hematology and Blood Transfusion, Prague, Czech Republic. 31 Vanderbilt University School of Medicine, Nashville, Tennessee, ... 46 Dana-Farber Cancer Institute, Boston, Massachusetts, United States. 47 University of California, San Diego, La Jolla, California, United States.
Hace 2 días · Treatment options for HER2-positive breast cancer brain metastases (BCBM) remain limited. We previously reported central nervous system (CNS) activity for neratinib and neratinib-capecitabine. Preclinical data suggest that neratinib may overcome resistance to ado-trastuzumab-emtansine (T-DM1) when given in combination. In TBCRC 022’s cohort 4, we examined the efficacy of neratinib plus T-DM1 ...
